A single exposure of male Xenopus laevis to estradiol-17-beta induces hepatic transcription of the genes coding for the egg yolk precursor protein, vitellogenin (VIT), and elicits the long-term induction of Xenopus estrogen receptor (XER) mRNA and serum retinol binding protein gene transcription. To study estrogen regulation of gene expression we developed stable Xenopus liver and fibroblast cell lines, cloned and expressed the Xenopus estrogen receptor (XER), and used mutagenesis and cotransfection to analyze the domain structure of the XER, and to identify regulatory sequences in the vitellogenin promoter. We have identified a far upstream palindrome related to the consensus estrogen response element (ERE) which may mediate autoregulation of XER gene expression. The putative XER ERE, and the native ERE, will be compared in transfections, and in binding and competition studies using our purified mutant XER. A specific transcription activation domain has not been identified in the XER or human ER. We shall test the ability of acidic amphipathic helices located in the hormone binding domain of the XER, and synthetic transcription activators, to increase the activity of wild type and mutant XER. We have overexpressed and purified a 111 amino acid XER mutant, which binds to the ERE and retains considerable ability to activate transcription. In a collaborative study, this mutant, and other XER mutants, will be bound to EREs separated by a few hundred nucleotides. We will examine the ability of the ERE-bound XER mutants to establish direct protein-protein contact by looping out the DNA. Electrophoresis, protein cross-linking using bifunctional reagents, and electron microscopy will be used to identify and characterize the complexes. Using purified XER mutants and our high efficiency HeLa cell transcription extract we will: (A) Correlate in vivo activity of mutant XERs with their ability to activate transcription in extracts. (B) Use our powerful synthetic ERE-TATA promoters as immobilized templates to begin to characterize the components of a simplified XER regulated transcription complex. (C) Use an immobilized native VIT promoter to determine whether the XER remains bound to the promoter during transcription, or dissociates after facilitating formation of an initiation complex involving an essential activator element we have identified. (D) The activator element linked to a TATA box is a powerful transcription activator, yet it is inactive in the VIT promoter unless XER is bound. We shall determine whether its activity is suppressed by unliganded XER, or by nucleosome phasing.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD016720-10
Application #
3313879
Study Section
Endocrinology Study Section (END)
Project Start
1982-07-01
Project End
1995-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Zhou, Jian-Hua; Yu, David V; Cheng, Jingwei et al. (2007) Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death. Steroids 72:765-77
Cheng, Jingwei; Yu, David V; Zhou, Jian-Hua et al. (2007) Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis. J Biol Chem 282:30535-43
Cheng, Jingwei; Zhang, Chen; Shapiro, David J (2007) A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Endocrinology 148:4634-41
Jiang, X; Ellison, S J; Alarid, E T et al. (2007) Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26:4106-14
Wang, Stanley; Zhang, Chen; Nordeen, Steven K et al. (2007) In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization. J Biol Chem 282:2765-75
Jiang, Xinguo; Orr, Brent A; Kranz, David M et al. (2006) Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells. Endocrinology 147:1419-26
Krieg, Adam J; Krieg, Sacha A; Ahn, Bonnie S et al. (2004) Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem 279:5025-34
Wang, Stanley Y; Ahn, Bonnie S; Harris, Rebecca et al. (2004) Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions. Biotechniques 37:807-8, 810-7
Kannan-Thulasiraman, Padma; Shapiro, David J (2002) Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J Biol Chem 277:41230-9
Krieg, S A; Krieg, A J; Shapiro, D J (2001) A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1). Mol Endocrinol 15:1971-82

Showing the most recent 10 out of 47 publications